Specialty medications, which are typically used to treat patients with complex, chronic conditions, continue to be a major area of pharmaceutical development and can have significant costs.
Although they represent approximately 2% of drug utilization, they account for nearly 8% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. Oversight remains essential to ensure appropriateness of therapy and to control impacts to pharmacy spend.
Watch the video blog here.
